Bosch, Jacobus J <br/><br/>
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Jan 2010 
 - 103-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-009-0729-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cancer Vaccines--immunology<br/>Cell Line, Tumor<br/>Endocytosis--immunology<br/>HLA-DR Antigens--immunology<br/>Histocompatibility Antigens Class II--biosynthesis<br/>Humans<br/>Lymphocyte Activation--immunology<br/>Melanoma--immunology<br/>Protein Transport--immunology<br/>Secretory Pathway<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Uveal Neoplasms--immunology